BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1949927)

  • 21. Urinary metabolites of caffeine in pregnant women.
    Scott NR; Chakraborty J; Marks V
    Br J Clin Pharmacol; 1986 Oct; 22(4):475-8. PubMed ID: 3768258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats.
    Kuh HJ; Shim CK
    Arch Pharm Res; 1994 Apr; 17(2):124-30. PubMed ID: 10319144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of clinically important interaction between erythromycin and theophylline.
    Hildebrandt R; Gundert-Remy U; Möller H; Weber E
    Eur J Clin Pharmacol; 1984; 26(4):485-9. PubMed ID: 6734707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers.
    Stoysich AM; Mohiuddin SM; Destache CJ; Nipper HC; Hilleman DE
    J Clin Pharmacol; 1991 Apr; 31(4):354-7. PubMed ID: 2037708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enoxacin--a potent inhibitor of theophylline metabolism.
    Beckmann J; Elsässer W; Gundert-Remy U; Hertrampf R
    Eur J Clin Pharmacol; 1987; 33(3):227-30. PubMed ID: 3480222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cigarette smoking and theophylline clearance and metabolism.
    Grygiel JJ; Birkett DJ
    Clin Pharmacol Ther; 1981 Oct; 30(4):491-6. PubMed ID: 7285483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers.
    Loi CM; Wei XX; Vestal RE
    Clin Pharmacol Ther; 1991 May; 49(5):571-80. PubMed ID: 2029830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid.
    Birkett DJ; Miners JO; Attwood J
    Br J Clin Pharmacol; 1983 Jan; 15(1):117-9. PubMed ID: 6849735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quantitative analysis of theophylline and its metabolites in urine of Chinese healthy subjects after oral administration of theophylline sustained-release tablets].
    Liu Y; Zhan Y; Zhang YF; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2014 Jul; 49(7):1039-43. PubMed ID: 25233637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake.
    Rybak ME; Sternberg MR; Pao CI; Ahluwalia N; Pfeiffer CM
    J Nutr; 2015 Apr; 145(4):766-74. PubMed ID: 25833779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of excretion characteristics of theophylline and its major metabolites.
    Jonkman JH; Tang D; Upton RA; Riegelman S
    Eur J Clin Pharmacol; 1981; 20(6):435-41. PubMed ID: 7286053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on the route of 1-methylurate formation in theophylline metabolism.
    Bayar C; Ozer I
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):415-9. PubMed ID: 9512943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tocainide on theophylline metabolism.
    Loi CM; Wei X; Parker BM; Korrapati MR; Vestal RE
    Br J Clin Pharmacol; 1993 Apr; 35(4):437-40. PubMed ID: 8485025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of mexiletine on theophylline pharmacokinetics in patients with bronchial asthma].
    Inafuku M; Suzuki T; Ohtsu F; Hariya Y; Nagasawa K; Yoshioka Y; Nakahara Y; Hayakawa H
    J Cardiol; 1992; 22(1):227-33. PubMed ID: 1284909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of urinary metabolites of theophylline to serum theophylline levels.
    Jenne JW; Nagasawa HT; Thompson RD
    Clin Pharmacol Ther; 1976 Mar; 19(3):375-81. PubMed ID: 1261172
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.
    Macias WL; Bergstrom RF; Cerimele BJ; Kassahun K; Tatum DE; Callaghan JT
    Pharmacotherapy; 1998; 18(6):1237-48. PubMed ID: 9855322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1986 Mar; 236(3):708-13. PubMed ID: 3485196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline.
    Kessler KM; Interian A; Cox M; Topaz O; De Marchena EJ; Myerburg RJ
    Am Heart J; 1989 Apr; 117(4):964-6. PubMed ID: 2929410
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral mexiletine-theophylline interaction.
    Katz A; Buskila D; Sukenik S
    Int J Cardiol; 1987 Nov; 17(2):227-8. PubMed ID: 3679607
    [No Abstract]   [Full Text] [Related]  

  • 40. The theophylline-enoxacin interaction: II. Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacin.
    Rogge MC; Solomon WR; Sedman AJ; Welling PG; Koup JR; Wagner JG
    Clin Pharmacol Ther; 1989 Oct; 46(4):420-8. PubMed ID: 2791445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.